Mustang Bio, Inc. (MBIO) stock
MBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$0.38−0.01 (-2.56%)
Close on Nov 18, 2026Market cap $2.88MP/E –Yield –
Mustang Bio enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Mustang Bio's enterprise value was -$12.35M on Nov 11, 2026, against -$13.98M a year earlier. Over the last 5 years it ranged from -$28.63M to $57.14M, with a median of -$6.08M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$12.35M | – |
| 2025 | Dec 31, 2025 | -$15.51M | – |
| 2024 | Dec 31, 2024 | -$410.99K | -130.6% |
| 2023 | Dec 29, 2023 | $1.34M | – |
| 2022 | Dec 30, 2022 | -$14.63M | -125.6% |
| 2021 | Dec 31, 2021 | $57.14M | -70.3% |
| 2020 | Dec 31, 2020 | $192.65M | +65.1% |
| 2019 | Dec 31, 2019 | $116.67M | +62.0% |
| 2018 | Dec 31, 2018 | $72.04M | -77.7% |
| 2017 | Dec 29, 2017 | $322.70M | – |
See a number that looks wrong?